Literature DB >> 2121308

The effects of chronic lithium treatment on psychomotor performance related to driving.

S Hatcher1, R Sims, D Thompson.   

Abstract

A group of 16 psychiatric out-patients in remission, who had been taking lithium carbonate as their sole medication for at least three months, were compared with a control group of 22 healthy volunteers. On a computerised driving simulator which produced measures of reaction time, tracking ability and mistakes made, the patient group had a significantly slower reaction time. Patients should be warned therefore that lithium may affect their ability to drive or operate machinery and that psychomotor impairment and sedation are not synonymous.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121308     DOI: 10.1192/bjp.157.2.275

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  7 in total

1.  [Driving ability with affective disorders and under psychotropic drugs].

Authors:  G Laux; A Brunnauer
Journal:  Nervenarzt       Date:  2014-07       Impact factor: 1.214

Review 2.  Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 3.  Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.

Authors:  Margaret K King; Marta Pardo; Yuyan Cheng; Kimberlee Downey; Richard S Jope; Eléonore Beurel
Journal:  Pharmacol Ther       Date:  2013-07-31       Impact factor: 12.310

Review 4.  Impact of psychotropic medications on simulated driving: a critical review.

Authors:  Mark J Rapoport; Melanie C Baniña
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report.

Authors:  Jussi Valtonen; Mira Karrasch
Journal:  Ther Adv Psychopharmacol       Date:  2020-04-28

6.  Neuropsychological exponents for the driving ability in remitted bipolar patients.

Authors:  Piotr Joachimiak; Krystyna Jaracz; Jan Jaracz
Journal:  Int J Bipolar Disord       Date:  2022-01-23

7.  Driving Performance Under Treatment of Most Frequently Prescribed Drugs for Mental Disorders: A Systematic Review of Patient Studies.

Authors:  Alexander Brunnauer; Florian Herpich; Peter Zwanzger; Gerd Laux
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.